pharmaphorum

NOVEMBER 14, 2022

A critical component of gathering this data is from company-reported emissions, and it is here where we can approach the task of quantifying the pharmaceutical industry’s progress. IQVIA examined the top 100 companies by global sales revenue (IQVIA MIDAS) and extracted data on commitments and progress (Figure 1).

Medicine 98

Medicine Pharmaceutical Healthcare Healthcare 98

pharmaphorum

NOVEMBER 11, 2022

Sadly not, says a new report from IQVIA, which looked specifically at the inclusion of Black/African Americans and Hispanics in clinical trials in recent years. The data show wide variability across disease areas and important “no notable improvement over the last decade,” according to IQVIA. for Hispanics.

Recruitment 78

Recruitment Pharma Education FDA 78

Pharmaceutical Technology

JULY 19, 2022

Mentions of cloud computing within the filings of companies in the pharmaceutical industry rose 65% between the final quarter of 2021 and the first quarter of 2022. To assess whether cloud computing is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated.

Pharmaceutical 98

Pharmaceutical 98

European Pharmaceutical Review

JULY 18, 2023

Some pharmaceutical companies are increasing their R&D spending to increase product numbers. With major pharmaceutical companies implementing these approaches, this is a major contributing factor to rapid growth of this sector. Also noted in the report was the shift towards cloud-based systems.

Marketing 92

Marketing Manufacturing Management Pharmaceutical manufacturing 92

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

World of DTC Marketing

DECEMBER 22, 2021

Models created by the medical research company IQVIA predict delayed diagnoses of an estimated 36,000 breast cancers and 19,000 colorectal cancers due to COVID-19’s scrambling of medical care. And a professor of neurology and epidemiology at Columbia University.

Patients 241

Patients Doctors Healthcare Healthcare 241

World of DTC Marketing

FEBRUARY 4, 2021

.” Let’s be honest: this is a way to inflate a company’s stock price whose past policies have all but removed all innovation. When a new employee goes thru orientation at Amgen, they are reminded that Amgen is a “right to work” company, which means they can terminate your employment anytime for any reason.

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

Pharma Marketing Network

JANUARY 18, 2023

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta).

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Marketing Networking 52

PM360

OCTOBER 3, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Advancing Breast Cancer Health Equity at the Point of Care” (Susan G.

Education 122

Education Marketing Media Management 122

pharmaphorum

JANUARY 26, 2023

We want to have conversations with companies as early as possible. Companies can engage through commercial surgeries at NHSE or through NICE’s scientific advice service and the Office for Market Access (OMA). Those costs are internal and reflect the fees that companies need to pay for at least two NICE appraisals.

Medicine 57

Medicine Patients Management Marketing 57

pharmaphorum

OCTOBER 27, 2022

However, fostering lasting and meaningful partnerships is not a simple task for life science companies. Company profile: ZS Associates. Recently, IQVIA teamed up with RefuAid to develop and deliver an employability event for 12 refugee pharmacists. The future of clinical research in neurology must be driven by community voices.

Patients 93

Patients Healthcare Healthcare Pharma 93

pharmaphorum

DECEMBER 2, 2022

It’s estimated that pharmaceutical and biotechnology companies spend between $7 billion and $8 billion ($US) annually to implement protocol amendments.* Natalia Kotchie, vice president, R&DS Applied Data Science Center, IQVIA. Cara Willoughby, senior director of design analytics, R&DS Applied Data Science Center, IQVIA.

Competition 96

Competition Leads Patients Electronics 96

Pharmaceutical Technology

AUGUST 9, 2022

Mentions of artificial intelligence within the filings of companies in the pharmaceutical industry fell 24% between the first and second quarters of 2022. To assess whether artificial intelligence is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated. of all sentences.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Technology

JULY 5, 2022

Mentions of the future of work within the filings of companies in the pharmaceutical industry were 373% higher between April 2021 and March 2022 than in 2016, according to the latest analysis of data from GlobalData. Secondly, we calculated the percentage of total analysed sentences that referred to the future of work.

Pharmaceutical 52

Pharmaceutical Management 52

pharmaphorum

DECEMBER 4, 2022

In fact, women hold only 11% of executive positions at Silicon Valley companies. I’ve been fortunate to work for companies that have supported my upward career trajectory, but I am cognizant that not every woman can say that. However, both industries share a common problem: failure to provide women with C-suite opportunities.

Pharma 97

Pharma Management Education Leads 97

pharmaphorum

JANUARY 4, 2023

The Japanese pharma and Gilead Sciences – which licensed US rights to Lexiscan to the Japanese company – won a temporary reprieve against the launch of the generic back in the autumn, winning a temporary stay on launch until 6 December. Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.

Pharmacology 57

Pharmacology Pharma Marketing Competition 57

pharmaphorum

SEPTEMBER 11, 2019

Another comes from the challenges developed markets face, which renews the urgency for pharma companies to spread their launch successes beyond traditionally core markets. To make sense of this landscape, this pharmaphorum webinar – in association with IQVIA – will look at the past, present and future of pharmaceutical launches.

Prescription 40

Prescription Marketing Pharma Pharmaceutical 40

pharmaphorum

NOVEMBER 25, 2022

Other organisations in the consortium include cancer hospitals in the Netherlands, Spain, Portugal and Italy, along with healthcare data company IQVIA and technology providers Siemens Healthcare, Elevate BV, CIAOTech and Ttopstart. The funding is being provided under the EU’s Horizon Europe programme.

Healthcare 89

Healthcare Healthcare Medicine Patients 89

pharmaphorum

JANUARY 25, 2023

So, how can companies maximise the effectiveness of customer engagement strategies when there are so many digital and physical mediums of interaction to choose from? Readily available algorithm libraries The level of data maturity across life sciences companies varies greatly.

Marketing 93

Marketing Sales Retail Management 93

pharmaphorum

OCTOBER 7, 2022

IQVIA has the long term market data, from World Reviews back to 1978, to investigate, and analysed nearly 30 years of launches into leading therapy classes, from multiple eras in the development of the pharmaceutical industry. What should companies do to give their launches the best chance in this environment? Is this true?

Competition 74

Competition Marketing Medicine Pharmaceutical 74

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Education 52

Education Marketing Media Biopharma 52

pharmaphorum

SEPTEMBER 26, 2022

According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas top products. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market. It was first launched in the US in 2008. .”

Pharmacology 52

Pharmacology FDA Pharma Marketing 52

PM360

SEPTEMBER 7, 2023

A recent study in JAMA found that ChatGPT-4 did a better job of identifying potential diagnoses in the NEJM challenge than most doctors,” explains David Stemler, Chief Creative Officer, CultHealth , An Indegene Company. Predictive models can identify patterns and risk factors associated with certain conditions or disease progression.

Patients 111

Patients Physicians Healthcare Healthcare 111

pharmaphorum

MARCH 18, 2020

Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.

Pharma 52

Pharma Government Medicine Healthcare 52

PM360

JULY 13, 2023

PM360 asked for companies to send in their latest and best ways to improve adherence. Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. Healthline Media Rx Medication Discount Service survey.

Education 89

Education Medical Media Patients 89

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

Marketing 52

Marketing Education Media Healthcare 52

Salesforce

JUNE 11, 2019

Biopharma companies have consistently had to reimagine themselves over the years to confront globalization, the entry of generics and biosimilars, and now the advent of precision medicine and value-based care. How can we help companies accelerate clinical innovation through impactful technology? I certainly don’t think so.

Pharma 52

Pharma Biopharma Recruitment Pharmaceutical 52

pharmaphorum

OCTOBER 9, 2018

These companies have to navigate a rapidly changing and increasingly complex landscape from pre-clinical valuation through foresight and planning at every stage of the asset life cycle - and at a time when Brexit adds uncertainty about regulatory approval and launch windows.

Marketing 52

Marketing Engineering Medicine Patients 52

European Pharmaceutical Review

DECEMBER 19, 2022

Although the joint-statement is said to be necessary owing to the “uncertainty among stakeholders on the use of biosimilars in clinical practice”, a 2021 report by IQVIA found that the volume of biosimilar prescribing across the European Economic Area generated €5.7 The Impact of Biosimilar Competition in Europe, IQVIA, December 2021.

Medicine 52

Medicine Biopharma Safety Food 52

pharmaphorum

NOVEMBER 23, 2017

Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights? Life sciences companies in particular, want to put this new data source in context with its already broad range of metrics. Achieving this calls for a step-by-step progression towards social media maturity.

Media 52

Media Pharma Marketing Leads 52

PM360

DECEMBER 20, 2023

With its rapidly evolving healthcare system, limited transparency of public information, and language barriers, China has never proven to be an easy market for overseas pharmaceutical companies to enter. market (source: IQVIA MIDAS, May 2023). in the top five European Union markets and 7.1% in the U.S. billion people in 2023).

Marketing 105

Marketing Insurance Medical Manufacturing 105

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Source: IQVIA Institute, March 2022. IQVIA Institute, March 2022. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

Prescription 52

Prescription Medical Distribution Patients 52

PM360

JUNE 11, 2022

As Leslie Harris and Bill Harris of Cobalt Communications explain in their article , “Only big pharma companies have the luxury of a wait-and-see strategy because they benefit from maintaining status quo. Smaller biotechs, however, must rely on judo principles to win against the bigger competitors.

Media 52

Media Doctors Marketing Competition 52

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. It is a forefront of the work that we are doing at IQVIA.”.

Medical 100

Medical Networking Healthcare Healthcare 100

pharmaphorum

MARCH 21, 2018

What does this mean for UK pharmaceutical companies that have historically focused on providing medicines and treatments? Technology, medicine, regulation and pricing have all evolved to a point where a collaborative, integrated system is not only possible, but desirable – and the data needed for it to become a reality is now available.

Pharma 40

Pharma Medicine Healthcare Healthcare 40

PM360

APRIL 22, 2024

In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them. WARREN RAYE Medthority Publishing Director, EPG Health, an IQVIA business New and emerging technologies present much potential to meet the educational needs of HCPs, now and in the near future.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

OCTOBER 26, 2022

But Giacomo Chiesi, head of Chiesi Global Rare Diseases, thinks of his 6,000-person company as a family business. And the company lives its commitment to patient centricity through all its operations, Chiesi explained. Every pharma company developing treatments for new diseases is contributing to some degree to better global health.

Patients 77

Patients Pharma Consulting Transportation 77